Financial Data and Key Metrics Changes - Total revenues for Q2 2026 were $12.7 million, down 3% from the prior year quarter, but would have been $13.4 million, up 5%, if a $1.1 million licensing deal for the Toxic Avenger was recognized [5][14] - Operating margins improved by 7% from the prior year quarter to 58% [5] - Net loss for the quarter was $5.5 million, compared to a net loss of $1.2 million in the prior year quarter [15] - Adjusted EBITDA was negative $3.7 million, down from positive $0.5 million in the prior year quarter [15] - Cash and cash equivalents were $2.3 million as of September 30, with $5.9 million available on a $12.5 million working capital facility [15][16] Business Line Data and Key Metrics Changes - The performance of the Toxic Avenger Unrated was below expectations at the box office, but it is expected to be profitable with an IRR of 40% due to strong ancillary distribution [6][9] - The company continues to focus on controlling costs and leveraging efficiencies from Cineverse Services India to manage SG&A spending [6] - The upcoming releases, Silent Night Deadly Night and Return to Silent Hill, are projected to follow a similar low-cost investment strategy [9] Market Data and Key Metrics Changes - Total streaming viewers reached 143.8 million, up 47% year over year, with total minutes streamed at 3.4 billion, up 45% [18] - SVOD subscribers grew to 1.39 million, a 6% increase year over year [18] - The Cineverse branded channel grew more than 6,400% in viewership since its relaunch in January [19] Company Strategy and Development Direction - The company is focusing on a fan-centric, IP-based film strategy, avoiding mixed-genre films in the future [31] - The Match Point technology sales pipeline is expanding, with dozens of potential partners actively evaluating the technology [12][23] - The MicroCo joint venture aims to become a leader in the micro-drama market, which is expected to represent a significant portion of streaming viewing time [24][25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence that investments made in sales, marketing, and technology will yield strong results in the remainder of the fiscal year and beyond [15][17] - The advertising environment is mixed, but there is optimism for growth as political spending ramps up in Q4 [20][21] - The company believes it is well-positioned for future growth with multiple engines of growth supported by technology and a growing audience [26] Other Important Information - The content library is now valued at $45 million, significantly above the $3.2 million book value [12][16] - The company is actively seeking strategic partnerships and acquisitions to enhance its technology offerings [24][40] Q&A Session Summary Question: Impact of Toxic Avenger's performance on future slate - Management believes the performance validated their theatrical releasing strategy and will influence future film selections to avoid mixed-genre movies [30][31] Question: Timing of monetization for Match Point - Management indicated that while the sales cycle is longer, there is strong interest from studios, and they expect significant revenue contributions in the next 12-24 months [32][33]

Core Insights - Cineverse Corp. reported total revenue of $12.4 million for Q2 FY 2026, a 3% decline year-over-year, primarily due to timing differences in revenue recognition for content licensing agreements [1][4][12] - The direct operating margin improved by 7 percentage points to 58% compared to the prior-year quarter, indicating solid performance across core business lines despite the revenue decline [2][13] - The company experienced a net loss of $(5.7) million, or $(0.31) per share, compared to a net loss of $(1.4) million, or $(0.09) per share, in the prior-year quarter [6][28] Financial Performance - Total quarterly revenue was $12.4 million, down from $12.7 million in the prior-year quarter, driven by gains in streaming, digital distribution, and theatrical sales [4] - Streaming and digital revenues decreased by 5% to $9.6 million, while base distribution revenue increased by 39% to $1.8 million, primarily due to the theatrical release of The Toxic Avenger Unrated [8] - SG&A expenses rose by 79% to $11.4 million, reflecting increased marketing costs and investments in the theatrical slate and technology group [5] Operational Developments - Cineverse announced the reissue of the 20th anniversary edition of Pan's Labyrinth, with a marketing campaign set to kick off at the Cannes Film Festival in May 2026 [3][16] - The company is advancing its MicroCo venture, a new studio for microseries, projected to reach a market size of $10 billion by 2027 [14][19] - The Toxic Avenger Unrated is projected to generate an internal rate of return (IRR) of over 40%, despite underperforming at the box office [2][15] Strategic Initiatives - Cineverse is expanding its technology partnerships and has signed four new customers for its Matchpoint™ media supply chain platform [18] - The company continues to build its content library, which is valued at $45 million, significantly above its book value of $3.2 million [9][17] - Management emphasizes a focus on profitability while pursuing growth through strategic partnerships and technology advancements [21]